Single-Nuclei RNA-Seq on Human Retinal Tissue Provides Improved Transcriptome Profiling

Total Page:16

File Type:pdf, Size:1020Kb

Single-Nuclei RNA-Seq on Human Retinal Tissue Provides Improved Transcriptome Profiling ARTICLE https://doi.org/10.1038/s41467-019-12917-9 OPEN Single-nuclei RNA-seq on human retinal tissue provides improved transcriptome profiling Qingnan Liang 1,2,3,9, Rachayata Dharmat1,2,8,9, Leah Owen4, Akbar Shakoor4, Yumei Li1, Sangbae Kim1, Albert Vitale4, Ivana Kim4, Denise Morgan4,5, Shaoheng Liang 6, Nathaniel Wu1, Ken Chen 6, Margaret M. DeAngelis4,5,7* & Rui Chen1,2,3* Single-cell RNA-seq is a powerful tool in decoding the heterogeneity in complex tissues by 1234567890():,; generating transcriptomic profiles of the individual cell. Here, we report a single-nuclei RNA- seq (snRNA-seq) transcriptomic study on human retinal tissue, which is composed of mul- tiple cell types with distinct functions. Six samples from three healthy donors are profiled and high-quality RNA-seq data is obtained for 5873 single nuclei. All major retinal cell types are observed and marker genes for each cell type are identified. The gene expression of the macular and peripheral retina is compared to each other at cell-type level. Furthermore, our dataset shows an improved power for prioritizing genes associated with human retinal dis- eases compared to both mouse single-cell RNA-seq and human bulk RNA-seq results. In conclusion, we demonstrate that obtaining single cell transcriptomes from human frozen tissues can provide insight missed by either human bulk RNA-seq or animal models. 1 HGSC, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA. 2 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston 77030 TX, USA. 3 Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA. 4 Department of Ophthalmology and Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA. 5 Department of Pharmacotherapy, the College of Pharmacy, University of Utah, Salt Lake City, UT 84132, USA. 6 Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. 7 Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA. 8Present address: St. Jude Children’s Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, USA. 9These authors contributed equally: Qingnan Liang, Rachayata Dharmat. *email: [email protected]; [email protected] NATURE COMMUNICATIONS | (2019) 10:5743 | https://doi.org/10.1038/s41467-019-12917-9 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12917-9 he retina is a heterogeneous tissue and is composed of Using the snRNA-seq approach, a total of 5873 nuclei are Tmultiple neuronal and non-neuronal cell types1. In the profiled from both the peripheral and macular region of three human retina, there is an ordered array of ~70 different frozen human donor retina samples. Through unsupervised cell types across five major neuron classes: photoreceptors (rods clustering of the gene expression profiles, clusters corresponding and cones), retinal ganglion cells (RGCs), horizontal cells (HC), to all seven major cell types in the human retina (rod, cone, MG, bipolar cells (BC), amacrine cells (AC), and a non-neuronal HC, AC, BC, and RGC) are identified. Differentially expressed Müller glial cell (MG), each playing a unique role in processing genes from each cell type are obtained. We compare the gene visual signals1,2. The transcriptome of the human retina has been expression profile between macular and peripheral region for reported using bulk tissue RNA-seq3,4, and the overall gene each cell types. Significantly higher expression of mitochondrial- expression profiles from different retinal regions (macular and electron transport genes is found in macular rod cells compared peripheral region) were compared to each other5. These studies to the expression of the peripheral ones, which may indicate that provided general transcriptomic information of the retina as a comparatively higher levels of oxidation stress exists in the whole tissue, but they could not reveal the entirety of the retina’s macular, providing a potential explanation of higher vulnerability complexity because it lacks individual cell-type resolution. In of macular rod cells during aging. In addition, as expected, addition, transcriptomic studies of selected cell types of the compared to the published mouse single-cell data, the single- human and primate retina were performed but were not sufficient nuclei human data show stronger predictive power in prioritizing in obtaining the complete profile of all major cell types6,7. The genes associated with human disease. Finally, we find that pho- profiles of individual cell types, particularly rare types that toreceptor DEGs significantly enrich inherited retinal disease account for a small portion of the retina, will offer important (IRD) genes, indicating that they can serve as a prioritization tool insights to the scientific knowledge of biology and disease. For for novel disease gene discovery and cell-specific pathway ana- example, particular cell types, such as the cone cells in the cone- lysis. Overall, our study reports a transcriptome profile of all rod dystrophy (CRD) and the retinal ganglion cells in glaucoma, major cell types of the human healthy retina at the resolution of are the first targets of the diseases8,9. However, both cell types are the individual cell, which would serve as a rich resource for the found in low proportions in the human retina and their tran- scientific community. scriptome profiles have not been well studied. Given the great benefit of obtaining the transcriptome at the individual cell type or at the individual cell level, single-cell RNA-seq on human Results retina tissue is an area of great interest. The generation of the snRNA-seq data of human retina.To Recently, single-cell RNA-seq studies have been performed on generate transcriptome profiles for human photoreceptor cells, mouse retina, both within the whole retina10 and within specifi- retinae from three separate, healthy donors were obtained (n = 3 cally sorted cell types11,12. These studies provided unprecedent- donors). All three donors were Caucasian, ages between 60 and edly high-resolution transcriptomic data of each cell types and 80 years old (Table 1), and were thoroughly examined as pre- allowed for novel cell subtype discovery. However, usage of viously described in the methods. Figure 1 shows an example of mouse datasets could be limiting given the considerable differ- the donor tissues used for this study. There was no visible ences between the human and mouse retina. For example, the pathogenic indication found, not even macular drusen, a hall- mouse retina lacks the macula region of the retina that is found in mark of age-related macular degeneration commonly found in humans and primates13,14, a structure that is essential for both this age group, according to the fundus images15. Two-sample high visual acuity and color vision perception in the retina. punches from each retina (n = 6), one from the macula region Mouse cone cells are also different from those of humans in their and the other from the peripheral region, were collected and wavelength-sensitive opsin expression patterns. Thus, we propose subjected to single-cell nuclei RNA-Seq. After dispensing, nano- that single-cell transcriptomic study on human retinal tissues will wells were imaged and only wells with single nuclei were selected. expand our knowledge of the retina and become a rich resource cDNA library construction and sequencing were performed for a for related research, such as human disease-related studies. total of 6542 individual nuclei. Distribution of the number of Unlike model-organism-based studies, more factors are nuclei from each sample is listed in Table 2. To exclude low- needed to be taken into consideration for human tissue studies quality data, several QC steps were conducted (described in the in order to provide reliable results. One of the major concerns methods). As a result, 669 nuclei were filtered out, leaving a total in profiling the transcriptome of post-mortem human tissues is number of 5873 nuclei for downstream analysis. On average, RNA integrity. This issue worsens in single-cell-level studies 31,186 mapped reads were obtained per nucleus, with the median because the dissociation of tissue occurs for an extended period number of genes detected at 1044. To further evaluate the quality of time after the retina is dissected. Thus, the dissociation itself of snRNA-Seq data, bulk RNA-seq from the corresponding could also lead to changes in transcription due to damage of the sample was performed. Good correlation between the bulk gene retina that might have occurred during the waiting period. expression (FPKM, paired-end seq) and single-nuclei gene Another concern is the health condition of the human tissue, expression (average of normalized read count after transforma- since studies using multiple individuals with differing health tion and 3′ end seq, see methods) was observed with positive conditions could potentially add complexity in proper inter- correlation coefficient ranges from 0.66 to 0.71 (all genes with pretation of the data. Here, we report a single-cell tran- non-zero expression were used with gene numbers ranging from scriptomic study on healthy human retina tissues using snRNA- 12163 to 13657, among six samples. Spearman correlation coef- seq. We tackle the potential issues by two approaches. The first ficient was used). consisted of using snRNA-seq instead of single-cell RNA-seq (scRNA-seq) to profile tissues confirmed as healthy by a strict Table 1 Medical information of the sample donors. post-mortem phenotyping. The second approach involved fl snRNA-seq, where tissues were ash-frozen immediately after Donor number Globe Age Sex Race dissection to preserve RNA integrity, minimizing the variation 12–887 OS (left eye) 78 F Caucasian due to differences in tissue dissociation conditions.
Recommended publications
  • Transcription-Induced DNA Double Strand Breaks: Both Oncogenic Force and Potential Therapeutic Target?
    Published OnlineFirst March 8, 2011; DOI: 10.1158/1078-0432.CCR-10-2044 Clinical Cancer Molecular Pathways Research Transcription-Induced DNA Double Strand Breaks: Both Oncogenic Force and Potential Therapeutic Target? Michael C. Haffner, Angelo M. De Marzo, Alan K. Meeker, William G. Nelson, and Srinivasan Yegnasubramanian Abstract An emerging model of transcriptional activation suggests that induction of transcriptional programs, for instance by stimulating prostate or breast cells with androgens or estrogens, respectively, involves the formation of DNA damage, including DNA double strand breaks (DSB), recruitment of DSB repair proteins, and movement of newly activated genes to transcription hubs. The DSB can be mediated by the class II topoisomerase TOP2B, which is recruited with the androgen receptor and estrogen receptor to regulatory sites on target genes and is apparently required for efficient transcriptional activation of these genes. These DSBs are recognized by the DNA repair machinery triggering the recruitment of repair proteins such as poly(ADP-ribose) polymerase 1 (PARP1), ATM, and DNA-dependent protein kinase (DNA-PK). If illegitimately repaired, such DSBs can seed the formation of genomic rearrangements like the TMPRSS2- ERG fusion oncogene in prostate cancer. Here, we hypothesize that these transcription-induced, TOP2B- mediated DSBs can also be exploited therapeutically and propose that, in hormone-dependent tumors like breast and prostate cancers, a hormone-cycling therapy, in combination with topoisomerase II poisons or inhibitors of the DNA repair components PARP1 and DNA-PK, could overwhelm cancer cells with transcription-associated DSBs. Such strategies may find particular utility in cancers, like prostate cancer, which show low proliferation rates, in which other chemotherapeutic strategies that target rapidly proliferating cells have had limited success.
    [Show full text]
  • Targeting Topoisomerase I in the Era of Precision Medicine Anish Thomas and Yves Pommier
    Published OnlineFirst June 21, 2019; DOI: 10.1158/1078-0432.CCR-19-1089 Review Clinical Cancer Research Targeting Topoisomerase I in the Era of Precision Medicine Anish Thomas and Yves Pommier Abstract Irinotecan and topotecan have been widely used as including the indenoisoquinolines LMP400 (indotecan), anticancer drugs for the past 20 years. Because of their LMP776 (indimitecan), and LMP744, and on tumor- selectivity as topoisomerase I (TOP1) inhibitors that trap targeted delivery TOP1 inhibitors using liposome, PEGyla- TOP1 cleavage complexes, camptothecins are also widely tion, and antibody–drug conjugates. We also address how used to elucidate the DNA repair pathways associated with tumor-specific determinants such as homologous recombi- DNA–protein cross-links and replication stress. This review nation defects (HRD and BRCAness) and Schlafen 11 summarizes the basic molecular mechanisms of action (SLFN11) expression can be used to guide clinical appli- of TOP1 inhibitors, their current use, and limitations cation of TOP1 inhibitors in combination with DNA dam- as anticancer agents. We introduce new therapeutic strate- age response inhibitors including PARP, ATR, CHEK1, and gies based on novel TOP1 inhibitor chemical scaffolds ATM inhibitors. Introduction DNA structures such as plectonemes, guanosine quartets, R-loops, and DNA breaks (reviewed in ref. 1). Humans encodes six topoisomerases, TOP1, TOP1MT, TOP2a, TOP2b, TOP3a, and TOP3b (1) to pack and unpack the approx- imately 2 meters of DNA that needs to be contained in the nucleus Anticancer TOP1 Inhibitors Trap TOP1CCs whose diameter (6 mm) is approximately 3 million times smaller. as Interfacial Inhibitors Moreover, the genome is organized in chromosome loops and the separation of the two strands of DNA during transcription and The plant alkaloid camptothecin and its clinical derivatives, replication generate torsional stress and supercoils that are topotecan and irinotecan (Fig.
    [Show full text]
  • The Role of Sumoylation of DNA Topoisomerase Iiα C-Terminal Domain in the Regulation of Mitotic Kinases In
    SUMOylation at the centromere: The role of SUMOylation of DNA topoisomerase IIα C-terminal domain in the regulation of mitotic kinases in cell cycle progression. By Makoto Michael Yoshida Submitted to the graduate degree program in the Department of Molecular Biosciences and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ________________________________________ Chairperson: Yoshiaki Azuma, Ph.D. ________________________________________ Roberto De Guzman, Ph.D. ________________________________________ Kristi Neufeld, Ph.D. _________________________________________ Berl Oakley, Ph.D. _________________________________________ Blake Peterson, Ph.D. Date Defended: July 12, 2016 The Dissertation Committee for Makoto Michael Yoshida certifies that this is the approved version of the following dissertation: SUMOylation at the centromere: The role of SUMOylation of DNA topoisomerase IIα C-terminal domain in the regulation of mitotic kinases in cell cycle progression. ________________________________________ Chairperson: Yoshiaki Azuma, Ph.D. Date approved: July 12, 2016 ii ABSTRACT In many model systems, SUMOylation is required for proper mitosis; in particular, chromosome segregation during anaphase. It was previously shown that interruption of SUMOylation through the addition of the dominant negative E2 SUMO conjugating enzyme Ubc9 in mitosis causes abnormal chromosome segregation in Xenopus laevis egg extract (XEE) cell-free assays, and DNA topoisomerase IIα (TOP2A) was identified as a substrate for SUMOylation at the mitotic centromeres. TOP2A is SUMOylated at K660 and multiple sites in the C-terminal domain (CTD). We sought to understand the role of TOP2A SUMOylation at the mitotic centromeres by identifying specific binding proteins for SUMOylated TOP2A CTD. Through affinity isolation, we have identified Haspin, a histone H3 threonine 3 (H3T3) kinase, as a SUMOylated TOP2A CTD binding protein.
    [Show full text]
  • Differential Expression of Multiple Disease-Related Protein Groups
    brain sciences Article Differential Expression of Multiple Disease-Related Protein Groups Induced by Valproic Acid in Human SH-SY5Y Neuroblastoma Cells 1,2, 1, 1 1 Tsung-Ming Hu y, Hsiang-Sheng Chung y, Lieh-Yung Ping , Shih-Hsin Hsu , Hsin-Yao Tsai 1, Shaw-Ji Chen 3,4 and Min-Chih Cheng 1,* 1 Department of Psychiatry, Yuli Branch, Taipei Veterans General Hospital, Hualien 98142, Taiwan; [email protected] (T.-M.H.); [email protected] (H.-S.C.); [email protected] (L.-Y.P.); fi[email protected] (S.-H.H.); [email protected] (H.-Y.T.) 2 Department of Future Studies and LOHAS Industry, Fo Guang University, Jiaosi, Yilan County 26247, Taiwan 3 Department of Psychiatry, Mackay Medical College, New Taipei City 25245, Taiwan; [email protected] 4 Department of Psychiatry, Taitung Mackay Memorial Hospital, Taitung County 95064, Taiwan * Correspondence: [email protected]; Tel.: +886-3888-3141 (ext. 475) These authors contributed equally to this work. y Received: 10 July 2020; Accepted: 8 August 2020; Published: 12 August 2020 Abstract: Valproic acid (VPA) is a multifunctional medication used for the treatment of epilepsy, mania associated with bipolar disorder, and migraine. The pharmacological effects of VPA involve a variety of neurotransmitter and cell signaling systems, but the molecular mechanisms underlying its clinical efficacy is to date largely unknown. In this study, we used the isobaric tags for relative and absolute quantitation shotgun proteomic analysis to screen differentially expressed proteins in VPA-treated SH-SY5Y cells. We identified changes in the expression levels of multiple proteins involved in Alzheimer’s disease, Parkinson’s disease, chromatin remodeling, controlling gene expression via the vitamin D receptor, ribosome biogenesis, ubiquitin-mediated proteolysis, and the mitochondrial oxidative phosphorylation and electron transport chain.
    [Show full text]
  • Modification of Topoisomerase Genes Copy Number in Newly Diagnosed
    Leukemia (2003) 17, 532–540 & 2003 Nature Publishing Group All rights reserved 0887-6924/03 $25.00 www.nature.com/leu Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia E Gue´rin1,2, N Entz-Werle´3, D Eyer3, E Pencreac’h1, A Schneider1, A Falkenrodt4, F Uettwiller3, A Babin3, A-C Voegeli1,5, M Lessard4, M-P Gaub1,2, P Lutz3 and P Oudet1,5 1Laboratoire de Biochimie et de Biologie Mole´culaire Hoˆpital de Hautepierre, Strasbourg, France; 2INSERM U381, Strasbourg, France; 3Service d’Onco-He´matologie Pe´diatrique Hoˆpital de Hautepierre, Strasbourg, France; 4Laboratoire Hospitalier d’He´matologie Biologique Hoˆpital de Hautepierre, Strasbourg, France; and 5INSERM U184, Illkirch, France Topoisomerase genes were analyzed at both DNA and RNA segregation.4 These enzymes act by promoting transient DNA levels in 25 cases of newly diagnosed childhood acute breakage in order to allow strand-passage events and DNA lymphoblastic leukemia (ALL). The results of molecular analy- 5 sis were compared to risk group classification of children in relaxation to occur before rejoining the broken DNA ends. order to identify molecular characteristics associated with Two types of DNA topoisomerases have been described. Type response to therapy. At diagnosis, allelic imbalance at topo- I enzymes, encoded in humans by the TOP1, TOP3A and isomerase IIa (TOP2A) gene locus was found in 75% of TOP3B genes,6–8 cleave only one strand of the DNA helix informative cases whereas topoisomerase I and IIb gene loci whereas type II enzymes, encoded by the human TOP2A and are altered in none or only one case, respectively.
    [Show full text]
  • Cyclin a Triggers Mitosis Either Via Greatwall Or Cyclin B
    bioRxiv preprint doi: https://doi.org/10.1101/501684; this version posted December 20, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Cyclin A triggers Mitosis either via Greatwall or Cyclin B Nadia Hégarat(1)*, Adrijana Crncec(1)*, Maria F. Suarez Peredoa Rodri- guez(1), Fabio Echegaray Iturra(1), Yan Gu(1), Paul F. Lang(2), Alexis R. Barr(3), Chris Bakal(4), Masato T. Kanemaki(5), Angus I. Lamond(6), Bela Novak(2), Tony Ly(7)•• and Helfrid Hochegger(1)•• (1) Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton BN19RQ, UK (2) Department of Biochemistry, University of Oxford, South Park Road, Oxford OX13QU, UK (3) MRC London Institute of Medical Science, Imperial College, London W12 0NN, UK (4) The Institute of Cancer Research, London SW3 6JB, UK (5) National Institute of Genetics, Research Organization of Information and Sys- tems (ROIS), and Department of Genetics, SOKENDAI (The Graduate University of Advanced Studies), Yata 1111, Mishima, Shizuoka 411-8540, Japan. (6) Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK (7) Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3BF, UK * Equal contribution ** Correspondence: Tony Ly: [email protected]; Helfrid Hochegger: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/501684; this version posted December 20, 2018.
    [Show full text]
  • TOP2B)Ina Patient with Acute Myeloid Leukemia with a New T(3;11)(P24;P15) Karin Nebral,1Helmut H
    Human Cancer Biology NUP98 Is Fused to Topoisomerase (DNA) IIB 18 0 kDa (TOP2B)ina Patient with Acute Myeloid Leukemia with a New t(3;11)(p24;p15) Karin Nebral,1Helmut H. Schmidt,2 Oskar A. Haas,1and Sabine Strehl1 Abstract Purpose: The nucleoporin 98 kDa (NUP98) gene has been reported to be fused to 17 different partner genes in various hematologic malignancies with11p15aberrations. Cytogenetic analysis of an adult de novo acute myelogenous leukemia (M5a) revealed a t(3;11)(p24;p15), suggesting rearrangement of NUP98 with a novel partner gene. Experimental Design: Fluorescence in situ hybridization (FISH) was used to confirm the involvement of NUP98 in the t(3;11)(p24;p15). Selection of possibleNUP98 partner genes was done by computer-aided analysis of the 3p24 region using the University of California Santa Cruz genome browser. Fusion gene ^ specific FISH and reverse transcription-PCR analyses were done to verify the presence of the new NUP98 fusion. Results: FISH analysis using a NUP98 -specific clone showed a split signal, indicating that the NUP98 gene was affected by the translocation. Of the genes localized at 3p24, TOP2B was selected as a possible fusion partner candidate gene. Dual-color fusion gene ^ specific FISH and reverse transcription-PCR analysis verified that NUP98 was indeed fused to TOP2B.Inaddition to reciprocal NUP98-TOP2B and TOP2B-NUP98 in-frame fusion transcripts, an alternatively spliced out-of-frame TOP2B-NUP98 transcript that resulted in a premature stop codon was detected. Analysis of the genomic breakpoints revealed typical signs of nonhomologous end joining resulting from error-prone DNA repair.
    [Show full text]
  • How Does SUMO Participate in Spindle Organization?
    cells Review How Does SUMO Participate in Spindle Organization? Ariane Abrieu * and Dimitris Liakopoulos * CRBM, CNRS UMR5237, Université de Montpellier, 1919 route de Mende, 34090 Montpellier, France * Correspondence: [email protected] (A.A.); [email protected] (D.L.) Received: 5 July 2019; Accepted: 30 July 2019; Published: 31 July 2019 Abstract: The ubiquitin-like protein SUMO is a regulator involved in most cellular mechanisms. Recent studies have discovered new modes of function for this protein. Of particular interest is the ability of SUMO to organize proteins in larger assemblies, as well as the role of SUMO-dependent ubiquitylation in their disassembly. These mechanisms have been largely described in the context of DNA repair, transcriptional regulation, or signaling, while much less is known on how SUMO facilitates organization of microtubule-dependent processes during mitosis. Remarkably however, SUMO has been known for a long time to modify kinetochore proteins, while more recently, extensive proteomic screens have identified a large number of microtubule- and spindle-associated proteins that are SUMOylated. The aim of this review is to focus on the possible role of SUMOylation in organization of the spindle and kinetochore complexes. We summarize mitotic and microtubule/spindle-associated proteins that have been identified as SUMO conjugates and present examples regarding their regulation by SUMO. Moreover, we discuss the possible contribution of SUMOylation in organization of larger protein assemblies on the spindle, as well as the role of SUMO-targeted ubiquitylation in control of kinetochore assembly and function. Finally, we propose future directions regarding the study of SUMOylation in regulation of spindle organization and examine the potential of SUMO and SUMO-mediated degradation as target for antimitotic-based therapies.
    [Show full text]
  • The Deubiquitinating Enzyme Inhibitor PR-619 Is a Potent DNA Topoisomerase II Poison
    Molecular Pharmacology Fast Forward. Published on September 12, 2019 as DOI: 10.1124/mol.119.117390 This article has not been copyedited and formatted. The final version may differ from this version. MOL # 117390 The deubiquitinating enzyme inhibitor PR-619 is a potent DNA topoisomerase II poison Ian G. Cowell, Elise M. Ling, Rebecca L. Swan, Matilda L. W. Brooks, & Caroline A. Austin Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne. NE2 4HH. U.K. (I.G.C., E.M.L, R.L.S., M.L.W.B,. & C.A.A.) Downloaded from molpharm.aspetjournals.org at ASPET Journals on September 27, 2021 1 Molecular Pharmacology Fast Forward. Published on September 12, 2019 as DOI: 10.1124/mol.119.117390 This article has not been copyedited and formatted. The final version may differ from this version. MOL # 117390 Running title: PR-619 is a TOP2 poison Corresponding authors To whom correspondence should be addressed: Dr Ian G. Cowell and Professor Caroline A. Austin Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4HH. United Kingdom Tel: +44 (0)191 208 7677 Fax: +44 (0)191 208 7424 Email: [email protected] Downloaded from Manuscript information 24 text pages including references and Figure legends 8 figures molpharm.aspetjournals.org 0 tables 48 number of references 185 words in abstract 586 words in Introduction 920 words in Discussion Non standard abbreviations at ASPET Journals on September 27, 2021 DMSO, Dimethyl sulfoxide; DSB, DNA double-strand break; DUB, deubiquitinating enzyme inhibitor; H2AX, histone H2A.X; γH2AX, S-139 phospho-histone H2A.X; TOP2A, DNA Topoisomerase IIα; TOP2B, DNA topoisomerase IIβ; TOP2, DNA topoisomerase II.
    [Show full text]
  • Identification of Novel Genes in BRCA1-Regulated Pathways
    Identification of Novel Genes in BRCA1-Regulated Pathways DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Shweta Kotian, M.S. Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2013 Dissertation Committee: Professor Jeffrey D. Parvin, Advisor Professor Joanna L. Groden Professor Denis C. Guttridge Professor Mark R. Parthun Copyright by Shweta Kotian 2013 Abstract BRCA1 is an important breast- and ovarian-specific tumor suppressor gene. It is important in various cellular functions in the body including transcriptional regulation, cell cycle checkpoint activation, DNA damage response, and maintenance of genomic stability. Approximately 40% of hereditary breast cancers have mutations in BRCA1 or BRCA2, and it is unclear how the remaining cases are caused, presumably by mutations or in the alteration of expression of unknown genes. We hypothesize that these unknown genes or ‘missing BRCAs’ can be identified by bio-informatics methods. Performing gene co-expression analysis, we have compared the expression profiles of hundreds of genes across publicly available breast cancer microarray datasets, with those of BRCA1 and BRCA2. We propose that the genes, whose expression is highly correlated with BRCA1 and BRCA2, might function together in the same pathways. They could also potentially interact with each other. The main aim of this study is to identify these genes, and then biologically validate them in functional BRCA1-regulated pathways including homologous recombination and centrosome duplication. We also hope to find any mechanistic ii associations between these genes and BRCA1. Eventually, we hope to evaluate if these genes contribute to the process of carcinogenesis.
    [Show full text]
  • Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA
    G C A T T A C G G C A T genes Review Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA Suguru Morimoto 1, Masataka Tsuda 1, Heeyoun Bunch 2 , Hiroyuki Sasanuma 1, Caroline Austin 3 and Shunichi Takeda 1,* 1 Department of Radiation Genetics, Graduate School of Medicine, Kyoto University, Yoshida Konoe, Sakyo-ku, Kyoto 606-8501, Japan; [email protected] (S.M.); [email protected] (M.T.); [email protected] (H.S.) 2 Department of Applied Biosciences, College of Agriculture and Life Sciences, Kyungpook National University, Daegu 41566, Korea; [email protected] 3 The Institute for Cell and Molecular Biosciences, the Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; [email protected] * Correspondence: [email protected]; Tel.: +81-(075)-753-4411 Received: 30 September 2019; Accepted: 26 October 2019; Published: 30 October 2019 Abstract: Type II DNA topoisomerase enzymes (TOP2) catalyze topological changes by strand passage reactions. They involve passing one intact double stranded DNA duplex through a transient enzyme-bridged break in another (gated helix) followed by ligation of the break by TOP2. A TOP2 poison, etoposide blocks TOP2 catalysis at the ligation step of the enzyme-bridged break, increasing the number of stable TOP2 cleavage complexes (TOP2ccs). Remarkably, such pathological TOP2ccs are formed during the normal cell cycle as well as in postmitotic cells. Thus, this ‘abortive catalysis’ can be a major source of spontaneously arising DNA double-strand breaks (DSBs).
    [Show full text]
  • Distinct Expression Patterns for Type II Topoisomerases IIA and IIB in the Early Foetal Human Telencephalon
    Harkin LF, Gerrelli D, Diaz DCG, Santos C, Alzu'bi A, Austin CA, Clowry GJ. Distinct expression patterns for type II topoisomerases IIA and IIB in the early foetal human telencephalon. Journal of Anatomy 2015, DOI: 10.1111/joa.12416 Copyright: © 2015 The Authors. Journal of Anatomy published by John Wiley & Sons Ltd on behalf of Anatomical Society. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. DOI link to article: http://dx.doi.org/10.1111/joa.12416 Date deposited: 18/12/2015 This work is licensed under a Creative Commons Attribution 4.0 International License Newcastle University ePrints - eprint.ncl.ac.uk Journal of Anatomy J. Anat. (2015) doi: 10.1111/joa.12416 Distinct expression patterns for type II topoisomerases IIA and IIB in the early foetal human telencephalon Lauren F. Harkin,1,2 Dianne Gerrelli,3 Diana C. Gold Diaz,3 Chloe Santos,3 Ayman Alzu’bi,1,2 Caroline A. Austin4 and Gavin J. Clowry1 1Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK 2Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK 3HDBR Resource, UCL Institute of Child Health, London, UK 4Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK Abstract TOP2A and TOP2B are type II topoisomerase enzymes that have important but distinct roles in DNA replication and RNA transcription. Recently, TOP2B has been implicated in the transcription of long genes in particular that play crucial roles in neural development and are susceptible to mutations contributing to neurodevelopmental conditions such as autism and schizophrenia.
    [Show full text]